Taking into account the standard deviation of the price estimate, the stock could hit a price target of $54 on the low end and $95 on the high end, according to the report.
AmSurg has a market cap of $3.94 billion.
More articles on transactions and valuation issues:
AmSurg shares increase nearly 15%: 4 key points
MFC posts quarterly earnings
Surgery Partners files for IPO: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
